NCT02217618View on ClinicalTrials.gov

A Study of LY2409021 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy Participants
Interventions
DRUG

LY2409021

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Daytona Beach

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT02217618 - A Study of LY2409021 in Healthy Participants | Biotech Hunter | Biotech Hunter